D R Abernethy

1.2k total citations
31 papers, 981 citations indexed

About

D R Abernethy is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, D R Abernethy has authored 31 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pharmacology. Recurrent topics in D R Abernethy's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Pharmaceutical studies and practices (5 papers). D R Abernethy is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug-Induced Hepatotoxicity and Protection (5 papers) and Pharmaceutical studies and practices (5 papers). D R Abernethy collaborates with scholars based in United States, Switzerland and France. D R Abernethy's co-authors include Richard I. Shader, David J. Greenblatt, Marcia Divoll, Barbara Ameer, Nabil Andrawis, Tracey Dickinson, J S Harmatz, D J Greenblatt, JM Egan and Irving W. Wainer and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Pharmacology and Experimental Therapeutics and Anesthesiology.

In The Last Decade

D R Abernethy

30 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D R Abernethy United States 16 278 204 182 155 149 31 981
S Freestone United Kingdom 19 292 1.1× 183 0.9× 105 0.6× 143 0.9× 107 0.7× 58 1.2k
A. J. J. Wood United States 18 294 1.1× 142 0.7× 179 1.0× 129 0.8× 136 0.9× 35 1.2k
Barry D. Zussman United Kingdom 15 218 0.8× 344 1.7× 86 0.5× 86 0.6× 253 1.7× 20 915
Edward J. Randinitis United States 18 232 0.8× 194 1.0× 371 2.0× 265 1.7× 246 1.7× 43 1.3k
DG Waller United Kingdom 17 241 0.9× 137 0.7× 178 1.0× 229 1.5× 104 0.7× 28 920
Arzu Gunes Sweden 15 265 1.0× 168 0.8× 83 0.5× 109 0.7× 221 1.5× 23 832
Allen A. Lai United States 17 153 0.6× 108 0.5× 197 1.1× 92 0.6× 206 1.4× 25 852
Stephen D. Wise Singapore 16 244 0.9× 207 1.0× 104 0.6× 101 0.7× 142 1.0× 29 985
Yukio Horai Japan 17 366 1.3× 355 1.7× 118 0.6× 169 1.1× 77 0.5× 35 1.3k
Raymond F. Johnson United States 22 250 0.9× 255 1.3× 418 2.3× 149 1.0× 72 0.5× 45 1.6k

Countries citing papers authored by D R Abernethy

Since Specialization
Citations

This map shows the geographic impact of D R Abernethy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D R Abernethy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D R Abernethy more than expected).

Fields of papers citing papers by D R Abernethy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D R Abernethy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D R Abernethy. The network helps show where D R Abernethy may publish in the future.

Co-authorship network of co-authors of D R Abernethy

This figure shows the co-authorship network connecting the top 25 collaborators of D R Abernethy. A scholar is included among the top collaborators of D R Abernethy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D R Abernethy. D R Abernethy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zineh, Issam, et al.. (2016). Improving the tools of clinical pharmacology: Goals for 2017 and beyond. Clinical Pharmacology & Therapeutics. 101(1). 22–24. 11 indexed citations
2.
Ling, S.M., Patrick Garnero, Ming Zhan, et al.. (2008). Serum protein signatures detect early radiographic osteoarthritis. Osteoarthritis and Cartilage. 17(1). 43–48. 57 indexed citations
3.
Ling, S.M., et al.. (2007). Electromyographic patterns suggest changes in motor unit physiology associated with early osteoarthritis of the knee. Osteoarthritis and Cartilage. 15(10). 1134–1140. 47 indexed citations
4.
Babaoğlu, Melih O., et al.. (2001). Polymorphic variant endothelial nitric oxide synthase impairs endothelium dependent vascular relaxation in both heterozygotes and homozygotes. Clinical Pharmacology & Therapeutics. 69(2). 4 indexed citations
5.
Scavone, Joseph M., et al.. (1997). Influence of Oral Contraceptive Use and Cigarette Smoking, Alone and Together, on Antipyrine Pharmacokinetics. The Journal of Clinical Pharmacology. 37(5). 437–441. 11 indexed citations
6.
Abernethy, D R, Irving W. Wainer, James Longstreth, & Nabil Andrawis. (1993). Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.. Journal of Pharmacology and Experimental Therapeutics. 266(2). 904–911. 43 indexed citations
7.
Abernethy, D R & Nabil Andrawis. (1993). Critical drug interactions: A guide to important examples. 19(10).
8.
Andrawis, Nabil, et al.. (1992). Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 879–884. 17 indexed citations
9.
Andrawis, Nabil & D R Abernethy. (1992). Verapamil blocks basal and angiotensin II-induced RNA synthesis of rat aortic vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 183(2). 767–773. 12 indexed citations
10.
Abernethy, D R, Laurence S. Kaminsky, & Tracey Dickinson. (1991). Selective inhibition of warfarin metabolism by diltiazem in humans.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 411–415. 32 indexed citations
11.
Abernethy, D R & Daniel L. Azarnoff. (1990). Pharmacokinetic Investigations in Elderly Patients. Clinical Pharmacokinetics. 19(2). 89–93. 13 indexed citations
12.
DePetrillo, Paolo B., et al.. (1990). High-performance liquid chromatographic determination of 3′,5′-cyclic adenosine monophosphate in human platelets. Journal of Chromatography B Biomedical Sciences and Applications. 527(2). 421–427. 6 indexed citations
13.
Dickinson, Tracey, et al.. (1990). Metabolite inhibition of parent drug biotransformation. Studies of diltiazem.. Drug Metabolism and Disposition. 18(2). 180–182. 18 indexed citations
14.
Burgunder, J‐M., D R Abernethy, & B H Lauterburg. (1988). Liver injury due to verapamil.. PubMed. 35(4). 169–70. 10 indexed citations
15.
Abernethy, D R, JM Egan, Tracey Dickinson, & George Carrum. (1988). Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 994–999. 18 indexed citations
16.
Dickinson, Tracey, JM Egan, & D R Abernethy. (1988). Effects of Nifedipine on Hepatic Drug Oxidation. Pharmacology. 36(6). 405–410. 4 indexed citations
17.
O’Neill, Padraig Gearoid, JM Egan, D R Abernethy, et al.. (1987). Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 252(3). H566–H577. 82 indexed citations
18.
Abernethy, D R, David J. Greenblatt, & Richard I. Shader. (1985). Imipramine and desipramine disposition in the elderly.. Journal of Pharmacology and Experimental Therapeutics. 232(1). 183–188. 114 indexed citations
19.
Arendt, R, David J. Greenblatt, John D. Bonin, et al.. (1983). In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution.. Journal of Pharmacology and Experimental Therapeutics. 227(1). 98–106. 124 indexed citations
20.
Abernethy, D R, David J. Greenblatt, Marcia Divoll, Barbara Ameer, & Richard I. Shader. (1983). Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.. Journal of Pharmacology and Experimental Therapeutics. 224(3). 508–513. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Freestone Breakdown of academic impact, for papers by A. J. J. Wood Breakdown of academic impact, for papers by Barry D. Zussman Breakdown of academic impact, for papers by Edward J. Randinitis Breakdown of academic impact, for papers by DG Waller Breakdown of academic impact, for papers by Arzu Gunes Breakdown of academic impact, for papers by Allen A. Lai Breakdown of academic impact, for papers by Stephen D. Wise Breakdown of academic impact, for papers by Yukio Horai Breakdown of academic impact, for papers by Raymond F. Johnson
Rankless by CCL
2026